Mindray (SZSE: 300760), a developer of healthcare technologies, announced on Monday that it launched its next-generation BeneVision V Series patient monitoring system at Euroanaesthesia 2025 in Lisbon, introducing a suite of innovations designed to elevate critical care through enhanced precision, mobility and workflow efficiency.

The new BeneVision V Series integrates with point-of-care ultrasound systems, including the TE Air handheld device, enabling real-time and trend-based ultrasound image analysis directly at the bedside. Powered by the upgraded HemoSight tool, the system synchronises ultrasound-derived parameters with vital signs to deliver a more complete hemodynamic profile for informed clinical decisions.

Mindray also introduced the MRV Pod, an industry-first, full-parameter cable-lite solution for wireless vital signs transmission. By removing bedside cables, the MRV Pod enhances patient mobility and streamlines clinical workflows. When used with the BeneVision N1 transport monitor, the solution enables uninterrupted monitoring during patient transfers.

The flagship VMAX model features a 4K UHD touchscreen in an ultra-slim form, with customisable displays, pinch-to-zoom waveform adjustment and 360-degree visible alarm lights to boost safety and usability in high-acuity environments.